Self-healing dental composites and related methods
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-006/083
A61K-006/08
C08K-009/10
출원번호
US-0809248
(2007-05-31)
등록번호
US-8735463
(2014-05-27)
발명자
/ 주소
Gross, Stephen M.
Latta, Mark A.
출원인 / 주소
Creighton University
대리인 / 주소
Advent, LLP
인용정보
피인용 횟수 :
1인용 특허 :
39
초록▼
Dental restorative composites having self-healing capabilities to repair discontinuities in the composite are provided. Dental restorative composites according to the present invention include a microsphere that encapsulates a monomer. When a fracture occurs, the microsphere is ruptured and the mono
Dental restorative composites having self-healing capabilities to repair discontinuities in the composite are provided. Dental restorative composites according to the present invention include a microsphere that encapsulates a monomer. When a fracture occurs, the microsphere is ruptured and the monomer fills the fracture. Depending on the monomer present in the microsphere, it is polymerized by a polymerization initiator or by an olefin metathesis catalyst present in the dental restorative composite. Self-healing dental restorative composites provide increased resistance to fracturing, and thus remain substantially intact for a longer period of time, preserving the remedial integrity of the dental repair or reconstruction.
대표청구항▼
1. A dental composition, comprising: a first monomer, wherein said first monomer includes one or more monomers selected from the group consisting of: 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl]propane (Bis-GMA), dimethacryloxyethyl 2,2,4-trimethylhexamethylene diurethane (UDMA), 1,6-bis-[2
1. A dental composition, comprising: a first monomer, wherein said first monomer includes one or more monomers selected from the group consisting of: 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl]propane (Bis-GMA), dimethacryloxyethyl 2,2,4-trimethylhexamethylene diurethane (UDMA), 1,6-bis-[2-methacryloxy-ethoxycarbonylamino]-2,2,4-trimethylhexane (UEDMA), triethyleneglycol dimethacrylate (TEGDMA), polyethylene glycol dimethacrylate (PEGDMA), glyceroldimethacrylate (GDM), methacryloyloxyethyl maleate (MEMA), diethyleneglycol dimethacrylate (DEGDMA), hexanediol dimethacrylate (HDMA), hexanediol diacrylate (HDDA), trimethylolpropanetriacrylate (TMPTA), trimethylolpropanetrimethacrylate (TMPTMA), ethoxylated trimethylolpropanetriacrylate (EOTMPTA), ethoxylated bisphenol A dimethacrylate (EBPADMA), isopropyl methacrylate; n-hexyl acrylate; stearyl acrylate; diallyl phthalate; divinyl succinate; divinyl adipate; divinyl phthalate; allyl acrylate; glycerol triacrylate; ethyleneglycol diacrylate; 1,3-propanediol di(meth)acrylate; decanediol dimethacrylate; 1,12-dodecanediol di(meth)acrylate; trimethylolpropane mono-(meth)acrylate; trimetfhylolpropane di-(meth)acrylate, trimethylolpropane triacrylate; butanediol di(meth)acrylate; 1,2,4-butanetriol trimethacrylate; 1,4-cyclohexanediol diacrylate; pentaerythritol tetra(meth)acrylate; sorbitol mono-, di-(meth)acrylate; sorbitol tri-(meth)acrylate; sorbitol tetra-(meth)acrylate; sorbitol penta-(meth)acrylate; sorbitol hexa-(meth)acrylate; tetrahydrofurfuryl (meth)acrylate; bis[1-(2-acryloxy)]-p-ethoxyphenyldimethylmethane; bis[1-(3-acryloxy-2-hydroxy)]-p-propoxyphenyldimethylmethane; 2,2,4-trimethylhexamethylene diisocyanate; tris-hydroxyethylisocyanurate trimethacrylate, glycerol phosphate monomethacrylates; glycerol phosphate dimethacrylates; hydroxyethyl methacrylate phosphates; 2-hydroxypropyl(meth)acrylate; citric acid di-methacrylates; citric acid tri-methacrylates; fluoropolymer-functional (meth)acrylates; poly(meth)acrylated polymaleic acid; poly(meth)acrylated polycarboxyl-polyphosphonic acid; poly(meth)acrylated polychlorophosphoric acid; poly(meth)acrylated polysulfonic acid; poly(meth)acrylated polyboric acid; polymerizable bisphosphonic acids, and siloxane-functional (meth)acrylate polysiloxanes,where the siloxane-functional (meth)acrylate polysiloxanes are defined as products resulting from hydrolytic polycondensation of one or more of the following silanes: bis[2-(2-(methacryloyl oxyethoxycarbonypethyl)]-3-triethoxysily-lpropyl amine, bis[2-(2(1)-(methacryloyloxypropoxycarbonyl(ethyl)]-3-triet-hoxysilylpropyl amine, 1,3(2)-dimethacryloyloxypropyl-[3-(3-triethoxysilyl-propyl)aminocarbonyl]propionate, 1,3(2)dimethacryloyloxypropyl-[4-(3-trie-thoxysilyl propyl)aminocarbonyl]butyrate, 1,3(2)dimethacryloyloxypropyl-[-4-(3-triethoxysilylpropyl)-N-iethylaminocarbonyl]butyrate, 3-[1,3(2)dimethacryloyloxypropyl)-2(3)-oxycarbonylamido]-propyltriethoxysilane, glycerol phosphate monomethacrylates, glycerol phosphate dimethacrylates, hydroxyethyl methacrylate phosphates, citric acid di-methacrylates, citric acid tri-methacrylates, poly(meth)acrylated oligomaleic acid, poly(meth)acrylated polymaleic acid, poly(meth)acrylated poly(meth)acrylic acid, poly(meth)acrylated polycarboxyl-polyphosphonic acid, poly(meth)acrylated polychlorophosphoric acid, poly(meth)acrylated polysulfonic acid, poly(meth)acrylated polyboric acid and polymerizable bisphosphonic acids;a polymerization initiator; anda microsphere encapsulating a second monomer, wherein said second monomer is released from said microsphere and polymerized by said polymerization initiator; wherein said first monomer is present outside said microsphere and, optionally, inside said microsphere. 2. The dental composition of claim 1, wherein said second monomer includes one or more monomers selected from the group consisting of: bis-3,4-epoxycyclohexylethylphenylmethylsilane, 3,4-epoxycyclohexylethylcyclopolymethylsiloxane, 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl]propane (Bis-GMA), dimethacryloxyethyl 2,2,4-trimethylhexamethylene diurethane (UDMA), 1,6-bis-[2-methacryloxy-ethoxycarbonylamino]-2,2,4-trimethylhexane (UEDMA), triethyleneglycol dimethacrylate (TEGDMA), polyethylene glycol dimethacrylate (PEGDMA), glyceroldimethacrylate (GDM), methacryloyloxyethyl maleate (MEMA), diethyleneglycol dimethacrylate (DEGDMA), hexanediol dimethacrylate (HDMA), hexanediol diacrylate (HDDA), trimethyloipropanetriacrylate (TM PTA), trimethylolpropanetrimethacrylate (TMPTMA), ethoxylated trimethylolpropanetriacrylate (EOTMPTA) and ethoxylated bisphenol A dimethacrylate (EBPADMA). 3. The dental composition of claim 1, wherein said microsphere accounts for about 2.5-14 wt % of a dental restorative composite. 4. A dental composition, comprising: a first monomer, wherein said first monomer includes one or more monomers selected from the group consisting of: 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl]propane (Bis-GMA), dimethacryloxyethyl 2,2,4-trimethylhexamethylene diurethane (UDMA), 1,6-bis-[2-methacryloxy-ethoxycarbonylamino]-2,2,4-trimethylhexane (UEDMA), triethyleneglycol dimethacrylate (TEGDMA), polyethylene glycol dimethacrylate (PEGDMA), glyceroldimethacrylate (GDM), methacryloyloxyethyl maleate (MEMA), diethyleneglycol dimethacrylate (DEGDMA), hexanediol dimethacrylate (HDMA), hexanediol diacrylate (HDDA), trimethyloipropanetriacrylate (TMPTA), trimethylolpropanetrimethacrylate (TMPTMA), ethoxylated trimethylolpropanetriacrylate (EOTMPTA), ethoxylated bisphenol A dimethacrylate (EBPADMA), isopropyl methacrylate; n-hexyl acrylate; stearyl acrylate; diallyl phthalate; divinyl succinate; divinyl adipate; divinyl phthalate; allyl acrylate; glycerol triacrylate; ethyleneglycol diacrylate; 1,3-propanediol di(meth)acrylate; decanediol dimethacrylate; 1,12-dodecanediol di(meth)acrylate; trimethylolpropane mono-(meth)acrylate; di-(meth)acrylate, trimethylolpropane triacrylate; butanediol di(meth)acrylate; 1,2,4-butanetriol trimethacrylate; 1,4-cyclohexanediol diacrylate; pentaerythritol tetra(meth)acrylate; sorbitol mono-penta-(meth)acrylate, di-penta-(meth)acrylate, tri-penta-(meth)acrylate, tetra-penta-(meth)acrylate, penta-(meth)acrylate; sorbitol hexa-(meth)acrylate; tetrahydrofurfuryl (meth)acrylate; bis[1-(2-acryloxy)]-p-ethoxyphenyldimethylmethane; bis[1-(3-acryloxy-2-hydroxy)]-ppropoxyphenyldimethylmethane; 2,2,4-trimethylhexamethylene diisocyanate; tris-hydroxyethylisocyanurate trimethacrylate, glycerol phosphate monomethacrylates; glycerol phosphate dimethacrylates; hydroxyethyl methacrylate phosphates; 2-hydroxypropyl(meth)acrylate; citric acid di-methacrylates; citric acid tri-methacrylates; fluoropolymer-functional (meth)acrylates; poly(meth)acrylated polymaleic acid; poly(meth)acrylated polycarboxyl-polyphosphonic acid; poly(meth)acrylated polychlorophosphoric acid; poly(meth)acrylated polysulfonic acid; poly(meth)acrylated polyboric acid; polymerizable bisphosphonic acids, and siloxane-functional (meth)acrylate polysiloxanes,where the siloxane-functional (meth)acrylate polysiloxanes are defined as products resulting from hydrolytic polycondensation of one or more of the following silanes: bis[2-(2-(methacryloyl oxyethoxycarbonyl(ethyl)]-3-′itriethoxysily-lpropyl amine, bis[2-(2(1)-(methacryloyloxypropoxycarbonyl)ethyl)]-3-triet-hoxysilylpropyl amine, 1,3(2)dimethacryloyloxypropyl-[3-(3-triethoxysilyl-propyl)aminocarbonyl]propionate, 1,3(2)dimethacryloyloxypropyl-[4-(3-trie-thoxysilyl propyl)aminocarbonyl]butyrate, 1,3(2)-dimethacryloyloxypropyl-[-4-(3-triethoxysilylpropyl)-N-′iethylaminocarbonyl]butyrate, 3-[1,3(2)dimethacryloyloxypropyl)-2(3)-oxycarbonylamidol]′propyltriethoxysilane, glycerol phosphate monomethacrylates, glycerol phosphate dimethacrylates, hydroxyethyl methacrylate phosphates, citric acid di-methacrylates, tri-methacrylates, poly(meth)acrylated oligomaleic acid, poly(meth)acrylated polymaleic acid, poly(meth)acrylated poly(meth)acrylic acid, poly(meth)acrylated polycarboxyl-polyphosphonic acid, poly(meth)acrylated polychlorophosphoric acid, poly(meth)acrylated polysulfonic acid, poly(meth)acrylated polyboric acid and polymerizable bisphosphonic acids;a polymerization initiator;a catalyst; anda first microsphere encapsulating a second monomer, wherein said second monomer is released from said first microsphere and polymerized by said catalystwherein said first monomer is present outside said microsphere and, optionally, inside said microsphere. 5. The dental composition of claim 4, wherein said second monomer includes one or more monomers selected from the group consisting of: cyclopentadienes; norbornenes; norbornadienes; 7-oxonorbornenes; azanorbornenes; cyclobutenes; cyclooctenes; cyclooctodienes; cyclooctatetraenes; acyclic dienes; and acetylenes. 6. The dental composition of claim 4, wherein said catalyst is encapsulated in a second microsphere. 7. The dental composition of claim 4, wherein said catalyst is a olefin metathesis catalyst. 8. The dental composition of claim 7, wherein said olefin metathesis catalyst is a Grubb's catalyst. 9. The dental composition of claim 4, wherein said first microsphere accounts for about 2.5-14 wt % of the dental composition. 10. The dental composition of claim 4, wherein said catalyst accounts for about 0.5-2 wt % of the dental composition.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (39)
Windisch, Mark Steven; Zhang, Xiaodong; Rusin, Richard Paul; Mitra, Sumita Basu, Clustered particle dental fillers.
Feldheim, Daniel L.; Marinakos, Stella M.; Shultz, David A., Nanoparticle composites and nanocapsules for guest encapsulation and methods for synthesizing same.
Yadav, Tapesh; Kostelecky, Clayton, Polymer nanocomposite implants with enhanced transparency and mechanical properties for administration within humans or animals.
Discher, Dennis E.; Discher, Bohdana M.; Won, You-Yeon; Lee, James C-M.; Bates, Frank S.; Hammer, Daniel A., Polymersomes and related encapsulating membranes.
Ostafin, Agnes E.; Nooney, Robert; Maginn, Edward, Process for making mesoporous silicate nanoparticle coatings and hollow mesoporous silica nano-shells.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.